AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21214919 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered questionnaire based on Azjen's Theory of Planned Behaviour
Number of subjects: 39
Study 19551404 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling
Number of subjects: 15
Study 19551404 — intervention group
Group type: COMPARATOR
Intervention: Running
Number of subjects: 15
Study 17108817 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic discectomy alone
Number of subjects: 280
Study 17108817 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic discectomy combined with 1000 U chymopapain
Number of subjects: 280
Study 15657472 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 % carbohydrate-electrolyte beverage
Number of subjects: 36
Study 15657472 — intervention group
Group type: COMPARATOR
Intervention: 6 % carbohydrate-electrolyte beverage
Number of subjects: 36
Study 11696050 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic nebulizer with low output of 0.87 mL/min
Number of subjects: 18
Study 11696050 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic nebulizer with high output of 1.90 mL/min
Number of subjects: 18
Study 9130894 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin-stimulated cycle
Number of subjects: 18
Study 7709771 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgibone (animal bone substitute harvested from steers)
Number of subjects: 0
Study 7709771 — intervention group
Group type: COMPARATOR
Intervention: Autologous bone graft
Number of subjects: 0
Study 2897516 — intervention group
Group type: COMPARATOR
Intervention: Standard anticoagulant control with rabbit brain thromboplastin (therapeutic range 18‐24 s; INR 2.5‐40)
Number of subjects: 210
Study 2897516 — intervention group
Group type: EXPERIMENTAL
Intervention: Less intensive regimen controlled with human brain thromboplastin (therapeutic range 26‐30 s; INR 2.0‐2.25)
Number of subjects: 210
Study 29467523 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose hydrocortisone (0.5 mg/kg twice per day for 7 days, followed by 0.5 mg/kg per day for 3 days)
Number of subjects: 100
Study 29467523 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 29467523 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose hydrocortisone
Number of subjects: 100
Study 27626182 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (N = 127)
Number of subjects: 255
Study 27626182 — intervention group
Group type: COMPARATOR
Intervention: Placebo (N = 128)
Number of subjects: 255
Study 24449007 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatosensory electrical stimulation to the paretic foot during a targeted stepping task
Number of subjects: 12
Study 24449007 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatosensory electrical stimulation to the paretic foot
Number of subjects: 12
Study 24449007 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatosensory electrical stimulation
Number of subjects: 12
Study 23552131 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT) + Optimal Medical Therapy (OMT)
Number of subjects: 0
Study 23552131 — intervention group
Group type: COMPARATOR
Intervention: Optimal Medical Therapy (OMT)
Number of subjects: 0
Study 20131031 — intervention group
Group type: EXPERIMENTAL
Intervention: lamivudine combined with SPNS
Number of subjects: 160
Study 20131031 — intervention group
Group type: COMPARATOR
Intervention: lamivudine only (Control)
Number of subjects: 160
Study 18678611 — intervention group
Group type: EXPERIMENTAL
Intervention: Rimonabant 20 mg/day
Number of subjects: 281
Study 18678611 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 281
Study 16922069 — intervention group
Group type: EXPERIMENTAL
Intervention: Cine magnetic resonance imaging using fast imaging employing steady-state acquisition (FIESTA) technique with parallel imaging
Number of subjects: 25
Study 12964176 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of amino acids (including lysine and serine)
Number of subjects: 29133
Study 12964176 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of lysine and serine
Number of subjects: 29133
Study 11317832 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg daily
Number of subjects: 0
Study 11317832 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.8 mg daily
Number of subjects: 0
Study 11317832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9103747 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-session cognitive-behavioral treatment (CBT12)
Number of subjects: 18
Study 9103747 — intervention group
Group type: COMPARATOR
Intervention: 4-session computer-assisted cognitive-behavioral treatment (CBT4-CA)
Number of subjects: 18
Study 8460755 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol and fentanyl combination
Number of subjects: 180
Study 8460755 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl alone
Number of subjects: 180
Study 8460755 — intervention group
Group type: COMPARATOR
Intervention: Propofol alone
Number of subjects: 180
Study 3943741 — intervention group
Group type: EXPERIMENTAL
Intervention: Lincoff temporary balloon buckle procedure
Number of subjects: 60
Study 3943741 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy and an episcleral radial silicone sponge explant
Number of subjects: 60
Study 28933254 — intervention group
Group type: EXPERIMENTAL
Intervention: Working Memory (WM) training
Number of subjects: 180
Study 28933254 — intervention group
Group type: COMPARATOR
Intervention: Placebo training
Number of subjects: 180
Study 27698600 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual Misoprostol (400 µg)
Number of subjects: 52
Study 27698600 — intervention group
Group type: COMPARATOR
Intervention: Vaginal Misoprostol (400 µg)
Number of subjects: 52
Study 25127240 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic L. rhamnosus GR‐1 and L. reuteri RC‐14 (2.5×10^9 CFU each)
Number of subjects: 14
Study 25127240 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic L. rhamnosus GR‐1 and L. reuteri RC‐14
Number of subjects: 14
Study 25127240 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 23075805 — intervention group
Group type: EXPERIMENTAL
Intervention: Remnant preservation technique (study group)
Number of subjects: 90
Study 23075805 — intervention group
Group type: COMPARATOR
Intervention: Standard technique (control group)
Number of subjects: 90
Study 21105282 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 65
Study 18773731 — intervention group
Group type: EXPERIMENTAL
Intervention: Napping
Number of subjects: 0
Study 18773731 — intervention group
Group type: COMPARATOR
Intervention: Non-napping
Number of subjects: 0
Study 15841891 — intervention group
Group type: EXPERIMENTAL
Intervention: Education and an educational pamphlet about the risks of glucocorticoid-induced osteoporosis, monitoring of drug therapy by pharmacists.
Number of subjects: 96
Study 15841891 — intervention group
Group type: COMPARATOR
Intervention: Usual and customary care (Control group).
Number of subjects: 96
Study 12459688 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine 100 microg/ml
Number of subjects: 143
Study 12459688 — intervention group
Group type: COMPARATOR
Intervention: Ephedrine 3 mg/ml
Number of subjects: 143
Study 12459688 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of phenylephrine 50 microg/ml and ephedrine 1.5 mg/ml
Number of subjects: 143
Study 10332905 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent apartments
Number of subjects: 303
Study 10332905 — intervention group
Group type: COMPARATOR
Intervention: Staffed group homes
Number of subjects: 303
Study 10332905 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance abuse treatment
Number of subjects: 303
Study 10332905 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician recommendations for group living
Number of subjects: 303
Study 10332905 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference for independent living
Number of subjects: 303
Study 7661160 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg b.i.d. plus amoxicillin 1 g t.i.d.
Number of subjects: 59
Study 7661160 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg b.i.d. plus amoxicillin 0.5 g t.i.d.
Number of subjects: 59
Study 7661160 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg b.i.d. plus amoxicillin 1 g suspension t.i.d. (re-treatment)
Number of subjects: 59
Study 7661160 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg b.i.d. plus amoxicillin 3 g (side effects)
Number of subjects: 59
Study 7661160 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg b.i.d. plus amoxicillin 1.5 g (side effects)
Number of subjects: 59
Study 1659570 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyglycolic acid pins
Number of subjects: 24
Study 1659570 — intervention group
Group type: COMPARATOR
Intervention: Kirschner wires
Number of subjects: 24
Study 7064879 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid, 10 mg daily for 3 months
Number of subjects: 47
Study 7064879 — intervention group
Group type: COMPARATOR
Intervention: Placebo (ascorbic acid, 10 mg daily for 3 months)
Number of subjects: 47
Study 31836300 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual sexual stimulation (AVSS) during penile Doppler ultrasound (PDU)
Number of subjects: 40
Study 31836300 — intervention group
Group type: COMPARATOR
Intervention: Intracavernous injection (ICI) alone
Number of subjects: 40
Study 30682573 — intervention group
Group type: EXPERIMENTAL
Intervention: pdC1‐INH liquid
Number of subjects: 75
Study 30682573 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 30793875 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care (SOC) HIV services
Number of subjects: 805
Study 30793875 — intervention group
Group type: EXPERIMENTAL
Intervention: Food assistance
Number of subjects: 805
Study 30793875 — intervention group
Group type: EXPERIMENTAL
Intervention: Cash transfer
Number of subjects: 805
Study 30793875 — intervention group
Group type: EXPERIMENTAL
Intervention: Food and cash transfers
Number of subjects: 805
Study 26934941 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradual withdrawal of remifentanil infusion
Number of subjects: 19
Study 26934941 — intervention group
Group type: EXPERIMENTAL
Intervention: Abrupt withdrawal of remifentanil infusion
Number of subjects: 19
Study 26934941 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 24611922 — intervention group
Group type: EXPERIMENTAL
Intervention: Interviewer-administered method
Number of subjects: 119
Study 24611922 — intervention group
Group type: COMPARATOR
Intervention: Self-administered method
Number of subjects: 119
Study 24611922 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 119
Study 22044694 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyphenon E (800 mg epigallocatechin gallate)
Number of subjects: 0
Study 22044694 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22044694 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyphenon E
Number of subjects: 0
Study 19680066 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n = 40)
Number of subjects: 60
Study 19680066 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 60
Study 17553467 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine ER (titrated from 37.5 mg to a maximum of 225 mg over 16 weeks)
Number of subjects: 293
Study 17553467 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine ER
Number of subjects: 293
Study 17553467 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 293
Study 15037872 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan 8-16 mg daily
Number of subjects: 4937
Study 12184416 — intervention group
Group type: EXPERIMENTAL
Intervention: Resected MTA (Group 1)
Number of subjects: 46
Study 12184416 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA placed as a retrograde root-end filling material (Group 2)
Number of subjects: 46
Study 9658723 — intervention group
Group type: EXPERIMENTAL
Intervention: Microsatellite analysis
Number of subjects: 41
Study 9658723 — intervention group
Group type: EXPERIMENTAL
Intervention: Microsatellite markers D2S123 and D18S58
Number of subjects: 41
Study 7806690 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine + Haloperidol + Benztropine
Number of subjects: 4
Study 7806690 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 4
Study 2562912 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 18
Study 2562912 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 18
Study 2562912 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 55715 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral disodium cromoglycate (2 g/day)
Number of subjects: 12
Study 55715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30064262 — intervention group
Group type: EXPERIMENTAL
Intervention: Underwater treadmill exercise for 30 minutes/day, three times/week for four weeks
Number of subjects: 80
Study 30064262 — intervention group
Group type: COMPARATOR
Intervention: Daily quadriceps exercise at home for 30 minutes (control group)
Number of subjects: 80
Study 27979820 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 96
Study 27979820 — intervention group
Group type: COMPARATOR
Intervention: Befriending
Number of subjects: 96
Study 25805451 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose delays and reductions
Number of subjects: 385
Study 25805451 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom interference
Number of subjects: 385
Study 25805451 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity of pain
Number of subjects: 385
Study 23673144 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 33
Study 23673144 — intervention group
Group type: COMPARATOR
Intervention: Valproate
Number of subjects: 33
Study 21375445 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological therapies (relaxation training, biofeedback, multimodal cognitive-behavioral therapy)
Number of subjects: 0
Study 21375445 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis and acceptance and commitment therapy
Number of subjects: 0
Study 19479152 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS with electrode placement on acupuncture points
Number of subjects: 45
Study 19479152 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS on non-acupuncture points along the same peripheral nerve
Number of subjects: 45
Study 19479152 — intervention group
Group type: COMPARATOR
Intervention: No stimulation (control)
Number of subjects: 45
Study 17087847 — intervention group
Group type: EXPERIMENTAL
Intervention: Vital capacity manoeuvre (VCM) followed by PEEP of 8 cm H2O
Number of subjects: 52
Study 17087847 — intervention group
Group type: COMPARATOR
Intervention: PEEP of 8 cm H2O
Number of subjects: 52
Study 16330291 — intervention group
Group type: EXPERIMENTAL
Intervention: RSG/MET (4 mg/2 g per day, escalated to 8 mg/2 g per day)
Number of subjects: 568
Study 16330291 — intervention group
Group type: COMPARATOR
Intervention: MET (2.5 g/d, escalated to 3 g/d)
Number of subjects: 568
Study 16330291 — intervention group
Group type: EXPERIMENTAL
Intervention: RSG/MET
Number of subjects: 568
Study 16330291 — intervention group
Group type: COMPARATOR
Intervention: MET
Number of subjects: 568
Study 11777672 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage-matched/tailored materials (Group 3)
Number of subjects: 1026
Study 11777672 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Group 1)
Number of subjects: 1026
Study 11777672 — intervention group
Group type: COMPARATOR
Intervention: Standard materials (Group 2)
Number of subjects: 1026
Study 9931670 — intervention group
Group type: EXPERIMENTAL
Intervention: Endarterectomy
Number of subjects: 0
Study 9931670 — intervention group
Group type: COMPARATOR
Intervention: Endovascular therapy
Number of subjects: 0
Study 8137477 — intervention group
Group type: EXPERIMENTAL
Intervention: PSK with 5‐FU (n = 15)
Number of subjects: 58
Study 8137477 — intervention group
Group type: EXPERIMENTAL
Intervention: lentinan with 5‐FU (n = 15)
Number of subjects: 58
Study 8137477 — intervention group
Group type: EXPERIMENTAL
Intervention: OK‐432 with 5‐FU (n = 12)
Number of subjects: 58
Study 8137477 — intervention group
Group type: COMPARATOR
Intervention: 5‐FU alone (n = 16)
Number of subjects: 58
Study 2737799 — intervention group
Group type: EXPERIMENTAL
Intervention: sustained-release capsule with breakfast
Number of subjects: 12
Study 2737799 — intervention group
Group type: COMPARATOR
Intervention: sustained-release capsule in fasting state
Number of subjects: 12
Study 2737799 — intervention group
Group type: COMPARATOR
Intervention: tablet form
Number of subjects: 12
Study 30325282 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Learning (DL) model for breast density assessment
Number of subjects: 5741
Study 28558789 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tRNS during reaching training
Number of subjects: 4
Study 28558789 — intervention group
Group type: COMPARATOR
Intervention: Sham tRNS during reaching training
Number of subjects: 4
Study 24907560 — intervention group
Group type: EXPERIMENTAL
Intervention: Repair
Number of subjects: 28
Study 24907560 — intervention group
Group type: COMPARATOR
Intervention: Replacement
Number of subjects: 28
Study 24099237 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg oral mosapride
Number of subjects: 18
Study 24099237 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 22141334 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular exercise program
Number of subjects: 100
Study 22141334 — intervention group
Group type: COMPARATOR
Intervention: Quadriceps strengthening program
Number of subjects: 100
Study 19783538 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate 30 mg kg(‐1) bolus + 10 mg kg(‐1) h(‐1) continuous infusion (Mg 30 group)
Number of subjects: 72
Study 19783538 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate 45 mg kg(‐1) bolus + 15 mg kg(‐1) h(‐1) continuous infusion (Mg 45 group)
Number of subjects: 72
Study 19783538 — intervention group
Group type: COMPARATOR
Intervention: Control group (i.v. saline)
Number of subjects: 72
Study 19783538 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate (both Mg 30 and Mg 45 groups)
Number of subjects: 72
Study 12531751 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone‐patellar tendon‐bone graft with metal interference screw fixation
Number of subjects: 99
Study 12531751 — intervention group
Group type: COMPARATOR
Intervention: Double‐looped hamstring tendons with metal plate fixation
Number of subjects: 99
Study 9922639 — intervention group
Group type: EXPERIMENTAL
Intervention: Wellness intervention (N = 211)
Number of subjects: 823
Study 9922639 — intervention group
Group type: COMPARATOR
Intervention: Historical control group (N = 413)
Number of subjects: 823
Study 9922639 — intervention group
Group type: COMPARATOR
Intervention: No wellness intervention (N = 147)
Number of subjects: 823
Study 9922639 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk population (N = 52)
Number of subjects: 823
Study 7781139 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepsulfam at 800 mg/m2
Number of subjects: 21
Study 7781139 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepsulfam at 640 mg/m2
Number of subjects: 21
Study 7781139 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepsulfam infused over 30 min
Number of subjects: 21
Study 7781139 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepsulfam infused over 2 h
Number of subjects: 21
Study 7781139 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepsulfam at 480 mg/m2
Number of subjects: 21
Study 7781139 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepsulfam at doses > or = 640 mg/m2
Number of subjects: 21
Study 7781139 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematopoietic stem cell support
Number of subjects: 21
Study 2332564 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (0.4 mg per day)
Number of subjects: 47
Study 2332564 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral budesonide (1.4 mg per day)
Number of subjects: 47
Study 2332564 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 7010511 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular steroid therapy (20 mg of triamcinalone hexacetonide)
Number of subjects: 48
Study 7010511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 31371386 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly retraining (1-month group)
Number of subjects: 28
Study 31371386 — intervention group
Group type: EXPERIMENTAL
Intervention: Every 3-month retraining (3-month group)
Number of subjects: 28
Study 31371386 — intervention group
Group type: COMPARATOR
Intervention: Control group (no retraining)
Number of subjects: 28
Study 28107234 — intervention group
Group type: EXPERIMENTAL
Intervention: Acrylic cage
Number of subjects: 64
Study 28107234 — intervention group
Group type: COMPARATOR
Intervention: PEEK cage
Number of subjects: 64
Study 26121832 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite acoustic therapy (personalized) for the first 30 days, followed by music therapy for the next 31-90 days.
Number of subjects: 96
Study 26121832 — intervention group
Group type: COMPARATOR
Intervention: Control group (no sound therapy).
Number of subjects: 96
Study 23433878 — intervention group
Group type: EXPERIMENTAL
Intervention: S+ (suction)
Number of subjects: 81
Study 23433878 — intervention group
Group type: EXPERIMENTAL
Intervention: AF (air flushing)
Number of subjects: 81
Study 21457214 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobetasol propionate 0·05% ointment (n = 30)
Number of subjects: 114
Study 21457214 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus 0·1% ointment (n = 31)
Number of subjects: 114
Study 21457214 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 29)
Number of subjects: 114
Study 19587362 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren 300 mg once daily
Number of subjects: 26
Study 19587362 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan 300 mg once daily
Number of subjects: 26